226
Views
22
CrossRef citations to date
0
Altmetric
Original Article

18β-Glycyrrhetic Acid Inhibits Immune Activation Triggered by HMGB1, a Pro-inflammatory Protein Found in the Tear Fluid during Conjunctivitis and Blepharitis

, PhD, , PhD, , MD, , PhD, , PhD, , MD & , MD, PhD show all
Pages 180-185 | Received 14 Jun 2010, Accepted 03 Nov 2010, Published online: 22 Mar 2011

REFERENCES

  • Landsman D, Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays. 1993: 15:539–546.
  • Yu SS, et al. Interaction of non-histone chromosomal proteins HMG1 and HMG2 with DNA. Eur J Biochem. 1977: 78:497–502.
  • Ellwood KB, et al. Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol Cell Biol. 2000: 20:4359–4370.
  • Allain FH, et al. Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding. EMBO J. 1999: 18:2563–2579.
  • Verrijdt G, et al. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem J. 2002: 361:97–103.
  • Bianchi ME. HMGB1 loves company. J Leukoc Biol. 2009: 86:573–576.
  • Scaffidi P, et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002: 418:191–195.
  • Bianchi ME. Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol. 2004: 14:287–293.
  • Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005: 5:331–342.
  • Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005: 17:359–365.
  • Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2006.
  • Dumitriu IE, et al. HMGB1: guiding immunity from within. Trends Immunol. 2005: 26:381–387.
  • Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 2006: 17:189–201.
  • Hoppe G, et al. Diurnal rhythm of the chromatin protein Hmgb1 in rat photoreceptors is under circadian regulation. J Comp Neurol. 2007: 501:219–230.
  • Pachydaki SI, et al. Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res. 2006: 82:807–815.
  • Arimura N, et al. High-mobility group box 1 protein in endophthalmitis. Graef’s Arch Clin Exp Ophtalmol. 2008: 246:1053–1058.
  • Arimura N, et al. Intraocular expression and release of high-mobility group box 1 protein in retinal detachment. Laboratory Investigation. 2009: 89:278–287.
  • Mollica L, et al. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol. 2007: 14:431–441.
  • Pedrazzi M, et al. Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling. J Immunol. 2007: 179:8525–8532.
  • Sitia G, et al. Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice. J Leukoc Biol. 2007: 81:100–107.
  • Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007: 81:1–5.
  • Gardella S, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002: 3:995–1001.
  • Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007: 220:35–46.
  • Watanabe T, et al. High mobility group box protein-1 in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 2009: 50:2283–2290.
  • Ulloa L, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A. 2002: 99:12351–12356.
  • Killeen ME, et al. The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J Pharmacol Exp Ther. 2006: 316:1070–1079.
  • Sakamoto R, et al. Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro. Biol Pharm Bull. 2001: 24:906–911.
  • van Rossum TG, et al. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol. 2001: 96:2432–2437.
  • Radi ZA, Render JA. The pathophysiologic role of cyclo-oxygenases in the eye. J Ocul Pharmacol Ther. 2008: 24:141–151.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.